Update to guidelines for pharmacological interventions for ASD, in NZ

In March 2011, there was a supplementary paper released updating the guidelines in New Zealand, for three pharmacological interventions for autism spectrum disorder (ASD). Those three interventions are aripiprazole, citalopram, and melatonin. This updates the 2008 government publication “New Zealand … Continue reading →